vs
Side-by-side financial comparison of Gogo Inc. (GOGO) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Gogo Inc. is the larger business by last-quarter revenue ($230.6M vs $207.8M, roughly 1.1× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -4.3%, a 61.7% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-25.4M).
Gogo Inc. is an American provider of in-flight broadband Internet service and other connectivity services for business aircraft, headquartered in Broomfield, Colorado. Through its Gogo LLC subsidiary, Gogo previously provided in-flight WiFi to 17 airlines until the Commercial Air business was sold to Intelsat for $400 million in December 2020. According to Gogo, over 2,500 commercial aircraft and 6,600 business aircraft have been equipped with its onboard Wi-Fi services. The company is the de...
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
GOGO vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | ||
|---|---|---|
| Revenue | $230.6M | $207.8M |
| Net Profit | $-10.0M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 6.2% | 52.2% |
| Net Margin | -4.3% | 57.4% |
| Revenue YoY | 67.3% | — |
| Net Profit YoY | 64.6% | 330.1% |
| EPS (diluted) | $-0.08 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $230.6M | — | ||
| Q3 25 | $223.6M | $207.8M | ||
| Q2 25 | $226.0M | — | ||
| Q1 25 | $230.3M | — | ||
| Q4 24 | $137.8M | — | ||
| Q3 24 | $100.5M | $0 | ||
| Q2 24 | $102.1M | $0 | ||
| Q1 24 | $104.3M | $0 |
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $-1.9M | $119.2M | ||
| Q2 25 | $12.8M | — | ||
| Q1 25 | $12.0M | — | ||
| Q4 24 | $-28.2M | — | ||
| Q3 24 | $10.6M | $-51.8M | ||
| Q2 24 | $839.0K | $-52.8M | ||
| Q1 24 | $30.5M | $-39.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 87.8% | — | ||
| Q1 25 | 87.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 6.2% | — | ||
| Q3 25 | 12.9% | 52.2% | ||
| Q2 25 | 15.9% | — | ||
| Q1 25 | 15.3% | — | ||
| Q4 24 | -17.5% | — | ||
| Q3 24 | 19.0% | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 33.2% | — |
| Q4 25 | -4.3% | — | ||
| Q3 25 | -0.9% | 57.4% | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | 5.2% | — | ||
| Q4 24 | -20.5% | — | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 29.2% | — |
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $-0.01 | $1.33 | ||
| Q2 25 | $0.09 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $0.08 | $-0.60 | ||
| Q2 24 | $0.01 | $-0.68 | ||
| Q1 24 | $0.23 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $125.2M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $101.1M | $1.1B |
| Total Assets | $1.3B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $125.2M | — | ||
| Q3 25 | $133.6M | $786.9M | ||
| Q2 25 | $102.1M | — | ||
| Q1 25 | $70.3M | — | ||
| Q4 24 | $41.8M | — | ||
| Q3 24 | $176.7M | $920.0M | ||
| Q2 24 | $161.6M | $701.7M | ||
| Q1 24 | $152.8M | $698.8M |
| Q4 25 | $101.1M | — | ||
| Q3 25 | $107.0M | $1.1B | ||
| Q2 25 | $102.8M | — | ||
| Q1 25 | $82.9M | — | ||
| Q4 24 | $69.3M | — | ||
| Q3 24 | $52.7M | $1.2B | ||
| Q2 24 | $52.0M | $931.7M | ||
| Q1 24 | $62.4M | $935.3M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $810.7M | $1.2B | ||
| Q2 24 | $802.7M | $973.7M | ||
| Q1 24 | $809.0M | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $8.5M | $142.2M |
| Free Cash FlowOCF − Capex | $-25.4M | $142.2M |
| FCF MarginFCF / Revenue | -11.0% | 68.4% |
| Capex IntensityCapex / Revenue | 14.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $65.1M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | — | ||
| Q3 25 | $46.8M | $142.2M | ||
| Q2 25 | $36.7M | — | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | $-38.3M | — | ||
| Q3 24 | $25.1M | $-49.2M | ||
| Q2 24 | $24.9M | $-32.9M | ||
| Q1 24 | $29.7M | $-43.8M |
| Q4 25 | $-25.4M | — | ||
| Q3 25 | $27.3M | $142.2M | ||
| Q2 25 | $33.5M | — | ||
| Q1 25 | $29.7M | — | ||
| Q4 24 | $-42.6M | — | ||
| Q3 24 | $20.7M | $-49.7M | ||
| Q2 24 | $21.6M | $-33.9M | ||
| Q1 24 | $28.2M | $-45.1M |
| Q4 25 | -11.0% | — | ||
| Q3 25 | 12.2% | 68.4% | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | -30.9% | — | ||
| Q3 24 | 20.6% | — | ||
| Q2 24 | 21.1% | — | ||
| Q1 24 | 27.0% | — |
| Q4 25 | 14.7% | — | ||
| Q3 25 | 8.7% | 0.0% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | 2.87× | — | ||
| Q1 25 | 2.70× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.36× | — | ||
| Q2 24 | 29.74× | — | ||
| Q1 24 | 0.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GOGO
| Services | $191.9M | 83% |
| Products | $38.7M | 17% |
| Fcc Reimbursement Program | $2.0M | 1% |
IDYA
Segment breakdown not available.